Company intelligence / Profile preview

Vikor Scientific

Charleston, South Carolina, United Statesvikorscientific.com ↗

Ownership: Private
Employees: ~204
Development stage: Commercial

Overview

Vikor Scientific offers commercialized rapid molecular diagnostic panels for pathogen and antibiotic resistance gene detection. Their solutions are used in clinical practice to guide therapy decisions and improve patient outcomes by providing actionable data within 24 hours. No drug or therapeutic clinical trial results apply.

Therapeutic areas: Infectious Diseases
Modalities: Molecular diagnostics
Industry: Molecular Diagnostics

Partnerships

Quantgene (partnership for CLIA-certified/CAP-accredited laboratory services in genomics/early cancer detection context)

Beyond the preview

Go deeper on Vikor Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vikor Scientific.

Explore the full profile